Skip to content

Suven Pharma gains as Advent targets 76% stake in it after open offer

Advent International will first acquire 50.1 percent stake in the company for Rs 6311 crore, at Rs 495 per share. Then it will launch an open offer for another 26 percent equity

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish